Correction

Leber A, Hontecillas R, Tubau-Juni N, Lichtiger S, Bassaganya-Riera J. Efficacy, Safety, and Tolerability of Omilancor in a Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of Patients With Ulcerative Colitis. Gastroenterology 2022;162(3S):S112 (abstract).

This entry was posted in News. Bookmark the permalink.